FICHTNER, ISABELLA
FICHTNER, ISABELLA
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
The role of extracellular vesicle-derived miRNA in the atherosclerotic burden
2025 A.S. Rizzuto, I. Fichtner, S. Carugo, A. Radeghieri, C. Macchi, M. Ruscica
Inhibition of ATP citrate lyase does not affect muscle mitochondrial activity in apoE-/- mice
2025 C. Macchi, I. Fichtner, T. Mohamed, E. Franchi, A.S. Rizzuto, C. Pavanello, J. Gindlhuber, S. Nerini, C.R. Sirtori, E. Osto, S. Carugo, M. Busnelli, G. Chiesa, V. Magnaghi, A. Corsini, M. Ruscica
Hypercholesterolemia and inflammation—Cooperative cardiovascular risk factors
2025 A. Gallo, W. Le Goff, R.D. Santos, I. Fichtner, S. Carugo, A. Corsini, C. Sirtori, M. Ruscica
PCSK9 and Coronary Artery Plaque—New Opportunity or Red Herring?
2024 L. Barbieri, G. Tumminello, I. Fichtner, A. Corsini, R.D. Santos, S. Carugo, M. Ruscica
Mitochondrial function in patients affected with fibromyalgia syndrome is impaired and correlates with disease severity
2024 C. Macchi, A. Giachi, I. Fichtner, S. Pedretti, P.S. Puttini, N. Mitro, A. Corsini, M. Ruscica, R. Gualtierotti
Lipoprotein(a) and the atherosclerotic burden – Should we wait for clinical trial evidence before taking action?
2024 I. Fichtner, C. Macchi, A.S. Rizzuto, S. Carugo, A. Corsini, M. Ruscica
Cardiometabolic risk factors in adults with cystic fibrosis undergoing elexacaftor/tezacaftor/ivacaftor therapy
2024 A. Gramegna, M. Ruscica, G. Leonardi, C. Macchi, I. Fichtner, G. Putti, M.C. Schianca, L. Terranova, G. Alicandro, F. Blasi
Vescicole extracellulari nel contesto dell'aterosclerosi = Extracellular vesicles in atherothrombosis
2024 M. Ruscica, A. Rizzuto, C. Macchi, I. Fichtner, S. Carugo, A. Corsini